Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates
Article first published online: 2 AUG 2012
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology
Clinical & Experimental Immunology
Volume 169, Issue 3, pages 302–310, September 2012
How to Cite
Degré, D., Lemmers, A., Gustot, T., Ouziel, R., Trépo, E., Demetter, P., Verset, L., Quertinmont, E., Vercruysse, V., Le Moine, O., Devière, J. and Moreno, C. (2012), Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clinical & Experimental Immunology, 169: 302–310. doi: 10.1111/j.1365-2249.2012.04609.x
- Issue published online: 2 AUG 2012
- Article first published online: 2 AUG 2012
- Accepted manuscript online: 7 MAY 2012 03:19AM EST
- Accepted for publication 26 April 2012
Fig. S1. Evolution of CCL2 plasma levels after 7 days of steroids therapy in 16 patients with severe alcoholic hepatitis (AH).
|CEI_4609_sm_FigureS1.tif||1906K||Supporting info item|
|CEI_4609_sm_FigureS1_legend.doc||20K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.